Hatch Launches Contactless Sleep Clock Targeting 37% of Dissatisfied U.S. Adults

The product launch targets a consumer segment identified by National Sleep Foundation data, testing whether wearable-adjacent hardware can convert a documented health gap into recurring revenue.

Hatch, a U.S. Consumer sleep technology company, is launching a new hardware product called the Hatch Sleep Clock, a contactless sleep tracker designed to monitor and modify sleep behavior without requiring the user to wear a device. CEO Ann Crady Weiss announced the launch in an interview with Bloomberg Businessweek Daily on September 1, 2026.

The launch is anchored to a statistic from a National Sleep Foundation poll cited by Bloomberg: approximately 37 percent of U.S. Adults, or nearly 4 in 10, report dissatisfaction with their sleep, and 60 percent report not getting enough sleep. The National Sleep Foundation poll is the stated basis for the market framing Weiss used in her Bloomberg interview.

The Hatch Sleep Clock is described as a contactless tracker, meaning it gathers sleep data without a wristband or sensor worn on the body. The specific sensing technology used in the device was not detailed in the Bloomberg interview, and Hatch has not published technical specifications in a public filing or press release reviewed for this article. What would clarify the sensing mechanism is a product specification sheet or regulatory filing with the U.S. Food and Drug Administration, if the device is classified as a medical instrument.

Hatch was founded in 2014 and is based in Redwood City, California. The company is privately held and has not filed public financial disclosures with the U.S. Securities and Exchange Commission. Its previously released products include the Hatch Rest, a combined sound machine and nightlight marketed primarily to parents of young children. The Sleep Clock represents the company's move into the adult sleep monitoring category.

The adult sleep hardware market in the United States includes competitors such as Oura, which makes a wearable ring that tracks sleep metrics, and Amazon, which sells the Halo Rise, a bedside contactless sleep tracker. Neither Oura nor Amazon's Halo division has reported standalone revenue figures for their sleep products in public disclosures reviewed for this article.

Weiss told Bloomberg that the goal of the Hatch Sleep Clock is to change sleep behavior, not simply to record it. The distinction is significant from a product positioning standpoint: devices that only track data compete in a crowded field, while devices that demonstrably alter behavior could support a subscription software layer, which carries higher recurring revenue margins than one-time hardware sales. Whether Hatch's device includes a subscription component was not confirmed in the Bloomberg interview or in any public filing reviewed for this article.

The broader consumer hardware environment in the United States has seen mixed results for sleep-focused products. Amazon discontinued its Halo wristband line in 2023 after the product failed to gain sufficient market adoption, according to reporting by The Verge at the time. That exit reduced the number of major platform companies directly competing in wearable sleep tracking at the mass market price point, though third-party and specialty devices remain available.

U.S. Consumer spending on health and wellness technology has held relatively stable even as overall discretionary spending has faced pressure from elevated interest rates. The Federal Reserve's benchmark federal funds rate target, as of its most recent statement, remains above pre-2022 levels, which has kept borrowing costs elevated for consumers financing large purchases. Hardware priced below the threshold requiring financing is less directly affected by rate levels, but overall consumer sentiment influences discretionary spending regardless of financing.

The National Sleep Foundation poll figure of 37 percent dissatisfied U.S. Adults translates to roughly 97 million people based on a U.S. Adult population of approximately 261 million, as estimated by the U.S. Census Bureau's 2025 population projections. That addressable figure does not represent a sales forecast and should not be interpreted as one. Conversion of health dissatisfaction into hardware purchases depends on price point, awareness, and clinical credibility, none of which Hatch has disclosed publicly for this product.

Hatch has not announced a retail price for the Sleep Clock or confirmed distribution channels beyond the Bloomberg interview. Pricing, distribution agreements, and whether the device will seek any form of FDA clearance are all unknown at this time. Public disclosure of any of those details would be required to assess the product's commercial prospects with greater precision.